Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Advertisement intended for health care professionals

Close

ASH Clinical News
ASH News Daily
ASH-SAP
Blood Journals
Hematology
The Hematologist
International
ASH
- ASH Home
- Research
- Education
- Advocacy
- Meetings
- Publications
- ASH Store

header search

search input Search input auto suggest

filter your search

Search

Menu

Issues
- Current Issue
- All Issues
First edition
Abstracts
Collections
Author Center
About

Skip Nav Destination

Update search

Querybuilder input 1 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 2 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 3 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 4 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 5 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 6 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

NARROW

Publications

Filter by publications

Blood (2)

Format

Filter by format

Journal Articles (2)

Article Type

Filter by article-type

Meeting Report (2)

Topics

Filter by topics

leukemia, myelocytic, chronic (2)
protein-tyrosine kinase inhibitor (2)
adverse event (1)
blood tests (1)
chest x-ray (1)
complete blood count (1)
dasatinib (1)
dry cough (1)
dyspnea (1)
electrolyte abnormality (1)

Date

Filter by date

Date range

Single date

From

To

Apply

Availability

Availability

1-2 of 2

Ross Maclean

Sort by

Sort Order Select

Journal Articles

Value of Survival Gains In Chronic Myelogenous Leukemia

Wesley Yin, John R Penrod, Ross Maclean, Jeffrey Humphrey, Erkut Bahceci, Darius Lakdawalla

Journal: Blood

Blood (2010) 116 (21): 4736.

https://doi.org/10.1182/blood.V116.21.4736.4736

Published: 2010

Journal Articles

Comparative Cost for Required Monitoring to Detect Adverse Events or Laboratory Abnormalities: Dasatinib Versus Nilotinib.

W. Robert Simons, Ross Maclean, Jessica Cairns

Journal: Blood

Blood (2009) 114 (22): 4524.

https://doi.org/10.1182/blood.V114.22.4524.4524

Published: 2009

Advertisement intended for health care professionals

Email alerts

First Edition Alert

Latest Issue Alert

Advertisement intended for health care professionals

Current Issue
First edition
All Issues

Collections
Abstracts
Authors

Submit to Blood
About Blood
Subscriptions

Public Access
Permissions
Alerts

Contact Us
Newsroom
Blood Classifieds

Advertising in Blood
Terms and Conditions
Twitter

American Society of Hematology
2021 L Street NW, Suite 900
Washington, DC 20036
TEL +1 202-776-0544
FAX +1 202-776-0545

ASH Publications

Blood
Blood Advances
Blood Neoplasia
Blood Vessels, Thrombosis & Hemostasis
Hematology, ASH Education Program
ASH Clinical News
ASH-SAP
The Hematologist

American Society of Hematology

ASH Home
Research
Education
Advocacy
Meetings
Publications
ASH Store

Copyright 2024 by American Society of Hematology

Privacy Policy
Cookie Policy
Terms of Use
Contact Us

This Feature Is Available To Subscribers Only

Sign In or Create an Account

Advertisement intended for health care professionals